SV Health Investors’ Dementia Discovery Fund (DDF) is the world’s largest family of specialized venture capital funds that invests exclusively in companies developing or enabling novel therapeutics for dementia. Dementias including Alzheimer’s Disease are arguably the largest unmet medical need with over 55m patients worldwide. With more than $550m raised for this strategy, and offices in London and Boston, DDF capitalizes on global investment opportunities to fulfill its dual mandate of delivering measurable impact and generating significant financial returns. Utilizing its network of venture partners, entrepreneurs, leading scientists, and strategic partners, DDF invests in and creates new biotech companies and provides thought leadership in the field. DDF is enabled by its limited partners including major pharmaceutical companies (Biogen, Bristol Myers Squibb, Eli Lilly and Co., GSK, Johnson & Johnson, Otsuka (Astex), Pfizer and Takeda), along with AARP, Aegon, British Business Bank, Gates Frontier, gradiant, UnitedHealth Group, and the non-profits the Alzheimer’s Association, Alzheimer’s Research UK and LifeArc.
Learn more at https://www.svhealthinvestors.com/ddf
Company Details
- Employees
- 30
- Founded
- -
- Address
- 71 Kingsway, London,england,united Kingdom
- Phone
- 1 617 367 8100
- dd****@****ors.com
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- theddfund.com
- HQ
- London, England
Sv Health Investors' Dementia Discovery Fund (Ddf) Questions
Sv Health Investors' Dementia Discovery Fund (Ddf)'s helpline number is 1 617 367 8100
Sv Health Investors' Dementia Discovery Fund (Ddf)'s website is theddfund.com
Sv Health Investors' Dementia Discovery Fund (Ddf)'s LinkedIn profile is https://uk.linkedin.com/company/dementia-discovery-fund
Sv Health Investors' Dementia Discovery Fund (Ddf) has
30 employees.
View email and phone details for 30
employees at Sv Health Investors' Dementia Discovery Fund (Ddf).
Sv Health Investors' Dementia Discovery Fund (Ddf)'s industry is
Venture Capital and Private Equity Principals
Sv Health Investors' Dementia Discovery Fund (Ddf)'s top competitors are
Aviadobio,
Cambridge Innovation Capital,
Trimtech Therapeutics Limited,
Alzheimer's Drug Discovery Foundation,
Dolby Family Ventures,
Endlyz Therapeutics,
Sv Health Investors,
Montara Therapeutics, Inc.,
Two Bear Capital,
Kdt Ventures.
Sv Health Investors' Dementia Discovery Fund (Ddf)'s support email address is ddfprojects@svhealthinvestors.com
Sv Health Investors' Dementia Discovery Fund (Ddf)'s categories are Venture Capital and Private Equity Principals
Sv Health Investors' Dementia Discovery Fund (Ddf)'s founding year is 2015
